HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the hear…
| Periodo | 2027-03 | 2026-11 | 2026-08 | 2026-05 |
|---|---|---|---|---|
| Real | — | $-0.05 | — | $-0.12 |
| Estimado | $-0.09 | $-0.09 | $-0.09 | $-0.13 |
| Sorpresa | — | +44.4% | — | +7.7% |
| Métrica | BEAT | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 58.3% | — |
| Operating Margin | — | -31.5% | — |
| Net Margin | — | -30.9% | — |
| FCF Margin | — | -10.6% | — |
| ROE | -807.3% | -36.3% | -771.1% |
| ROA | -359.7% | -29.8% | -329.8% |
| Current Ratio | — | 2.68 | — |
| Debt / Equity | — | 0.28 | — |
| Tendencia (Piotroski) | FY25 | FY24 |
|---|---|---|
| ✗Rentabilidad sobre activos positiva | -359.7% | — |
| ✗Flujo de caja operativo positivo | −$14M | −$14M |
| ✓Rentabilidad sobre activos al alza | -359.7% | -593.7% |
| ✓Caja operativa/activos supera al ROA | -239.4% | ROA -359.7% |
| –Menos deuda a largo plazo | — | — |
| ✗Mejor liquidez (ratio corriente) | — | — |
| ✗Sin aumentar el nº de acciones | 34M | 27M |
| –Margen bruto al alza | — | — |
| –Rotación de activos al alza | — | — |
| Calidad del negocio | FY25 |
|---|---|
| ✗ROCE > 10 % | -812.1% |
HeartBeam, Inc. cotiza a 0.40 USD y tiene una capitalización bursátil de $25M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud